Cases 31 - 40 of 54
Puracap Pharmaceutical, LLC et al v. Exelan Pharmaceuticals, Inc.
as 1:2015cv08222
Plaintiff:
Puracap Pharmaceutical, LLC
Defendant:
Invagen Pharmaceuticals, Inc. and Exelan Pharmaceuticals, Inc.
Cause Of Action: 28 U.S.C. § 1332
BOEHRINGER INGELHEIM PHARMACEUTICALS INC. et al v. HEC PHARM CO., LTD. et al
as 3:2015cv05982
Plaintiff:
BOEHRINGER INGELHEIM PHARMACEUTICALS INC. , BOEHRINGER INGELHEIM INTERNATIONAL GMBH , BOEHRINGER INGELHEIM CORPORATION and others
Defendant:
HEC PHARM GROUP , HEC PHARM CO., LTD. , HEC PHARM USA and others
Counter_claimant:
SUN PHARMACEUTICAL INDUSTRIES, INC. , SUN PHARMACEUTICAL INDUSTRIES LTD. , SUN PHARMA GLOBAL FZE and others
Counter_defendant:
BOEHRINGER INGELHEIM CORPORATION , BOEHRINGER INGELHEIM INTERNATIONAL GMBH , BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Forest Laboratories LLC et al v. InvaGen Pharmaceuticals Inc.
as 1:2015cv00277
Plaintiff:
Forest Laboratories LLC , Forest Laboratories Holdings Ltd. , Merck KGaA and others
Defendant:
InvaGen Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
SHIRE DEVELOPMENT LLC et al v. INVAGEN PHARMACEUTICALS, INC.
as 2:2015cv00367
Plaintiff:
SHIRE DEVELOPMENT LLC , SHIRE CANADA INC. and SHIRE INTERNATIONAL LICENSING B.V.
Defendant:
INVAGEN PHARMACEUTICALS INC.
Counter_claimant:
INVAGEN PHARMACEUTICALS INC.
Counter_defendant:
SHIRE CANADA INC., SHIRE DEVELOPMENT LLC and SHIRE INTERNATIONAL LICENSING B.V.
Cause Of Action: 35 U.S.C. § 271
SUMITOMO DAINIPPON PHARMA CO., LTD. et al v. INVAGEN PHARMACEUTICALS, INC.,
as 2:2015cv00281
Plaintiff:
SUMITOMO DAINIPPON PHARMA CO., LTD. and SUNOVION PHARMACEUTICALS INC.
Defendant:
INVAGEN PHARMACEUTICALS, INC.,
Counter_claimant:
INVAGEN PHARMACEUTICALS, INC.,
Counter_defendant:
SUMITOMO DAINIPPON PHARMA CO., LTD. and SUNOVION PHARMACEUTICALS INC.
Cause Of Action: 35 U.S.C. § 145
SUMITOMO DAINIPPON PHARMA CO., LTD. et al v. INVAGEN PHARMACEUTICALS, INC.,
as 3:2015cv00281
Plaintiff:
SUMITOMO DAINIPPON PHARMA CO., LTD. and SUNOVION PHARMACEUTICALS INC.
Defendant:
INVAGEN PHARMACEUTICALS, INC.
Cause Of Action: 35 U.S.C. § 145
Shire Development LLC et al v. InvaGen Pharmaceuticals, Inc.
as 2:2014cv07263
Counter Claimant:
InvaGen Pharmaceuticals, Inc. and InvaGen Pharmaceuticals, Inc.
Defendant:
InvaGen Pharmaceuticals, Inc.
Counter Defendant:
Shire Canada Inc., Shire Canada Inc., Shire Development LLC and others
Plaintiff:
Shire Canada Inc., Shire Development LLC and Shire International Licensing B.V.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Roxane Laboratories, Inc. v. Camber Pharmaceuticals, Inc. et al
as 2:2014cv04042
Plaintiff:
Roxane Laboratories, Inc.
Defendant:
CAMBER PHARMACEUTICALS INC. and INVAGEN PHARMACEUTICALS INC.
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
Roxane Laboratories, Inc. v. Camber Pharmaceuticals, Inc. et al
as 2:2014cv00232
Plaintiff:
Roxane Laboratories, Inc.
Defendant:
Camber Pharmaceuticals, Inc. and InvaGen Pharmaceuticals, Inc.
Cause Of Action: 15 U.S.C. § 1126
JANSSEN PRODUCTS, L.P. et al v. HETERO DRUGS, LTD. et al
as 2:2013cv01444
Plaintiff:
JANSSEN PRODUCTS, L.P. and JANSSEN R&D IRELAND
Defendant:
HETERO DRUGS, LTD. , UNIT III and INVAGEN PHARMACEUTICALS, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
